Health and Healthcare

Merck : MRK

All Merck Articles

1088 Articles

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2016 at 8:05 AM EDT

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out and it almost feels like short sellers are…

Paul Ausick | Aug 9, 2016 at 4:01 PM EDT

Amex, DuPont Drag on DJIA Tuesday

August 9, 2016: Markets opened higher again Tuesday following the lead of Asian and European exchanges. The productivity report cooled…

Paul Ausick | Aug 8, 2016 at 4:01 PM EDT

Healthcare Stocks Sink DJIA on Monday

August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red…

Jon C. Ogg | Aug 8, 2016 at 12:45 PM EDT

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise…

Paul Ausick | Aug 5, 2016 at 4:01 PM EDT

Merck Dominates DJIA Boost Friday

August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial…

Chris Lange | Aug 5, 2016 at 10:35 AM EDT

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was…

Paul Ausick | Jul 29, 2016 at 8:20 AM EDT

Merck Raises EPS Outlook After Q2 Earnings

Merck reported better-than-expected second-quarter 2016 results before markets opened Friday morning.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Chris Lange | Jul 24, 2016 at 10:50 AM EDT

Top Dow Earnings for the Week Ahead

Overall, one-third of the Dow Jones Industrial Average is reporting this week, and this has the potential to sustain the…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Paul Ausick | Jul 6, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA Wednesday

July 6, 2016: Markets opened lower again Wednesday, following international markets that traded lower overnight. The British pound posted a…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Paul Ausick | Jun 29, 2016 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow Wednesday

June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

1 … 35 36 37 38 39 … 73

Merck : MRK

All Merck Articles

Major Pharma Short Interest Slides

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Amex, DuPont Drag on DJIA Tuesday

Healthcare Stocks Sink DJIA on Monday

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Merck Dominates DJIA Boost Friday

Why Bristol-Myers Failure Is a Huge Win for Merck

Merck Raises EPS Outlook After Q2 Earnings

Short Sellers Get Selective on Major Pharma

Top Dow Earnings for the Week Ahead

Short Sellers Run for Cover From Major Pharma

The 4 Stocks That Lifted the DJIA Wednesday

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Boosted the Dow Wednesday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

Alphabet Just Cut Share Buybacks To $0, While Acquiring A $40 Billion Stake In A Rival AI Company

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

American Airlines or Lockheed Martin: Wall Street Expects One to Soar on Earnings, One to Stumble

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

Merck : MRK

All Merck Articles

Major Pharma Short Interest Slides

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Amex, DuPont Drag on DJIA Tuesday

Healthcare Stocks Sink DJIA on Monday

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Merck Dominates DJIA Boost Friday

Why Bristol-Myers Failure Is a Huge Win for Merck

Merck Raises EPS Outlook After Q2 Earnings

Short Sellers Get Selective on Major Pharma

Top Dow Earnings for the Week Ahead

Short Sellers Run for Cover From Major Pharma

The 4 Stocks That Lifted the DJIA Wednesday

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Boosted the Dow Wednesday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

Alphabet Just Cut Share Buybacks To $0, While Acquiring A $40 Billion Stake In A Rival AI Company

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

Featured Reads

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000